Medifast (MED) Retained Earnings (2010 - 2026)

Medifast has reported Retained Earnings for 17 years, with the latest figure at $156.1 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 11.29% year-over-year to $156.1 million; the trailing twelve-month figure through Mar 2026 stood at $156.1 million (down 11.29% YoY), and the FY2025 full-year result was $234000.0, down 99.87% from the prior year.
• Retained Earnings for Q1 2026 stood at $156.1 million, up from $234000.0 in the prior quarter.
• The five-year high for Retained Earnings was $203.1 million in Q1 2022, with the low at $22000.0 in Q1 2024.
• Historically, Retained Earnings has averaged $105.4 million across 5 years, with a median of $139.9 million in 2022.
• Annual changes were most pronounced in 2024 — Retained Earnings plunged 99.99% — and 2025, when it soared 799954.55%.
• Medifast's Retained Earnings stood at $139.9 million in 2022, then slumped by 99.82% to $248000.0 in 2023, then surged by 71183.06% to $176.8 million in 2024, then plunged by 99.87% to $234000.0 in 2025, then soared by 66630.34% to $156.1 million in 2026.
• The last three Retained Earnings figures came in at $156.1 million (Q1 2026), $234000.0 (Q4 2025), and $176.2 million (Q3 2025), per Business Quant data.